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Background: Minimally invasive esophagectomy (MIE) has consistently been associated with improved 
perioperative outcome and similar oncological safety compared to open esophagectomy. However, it is 
currently unclear what type of MIE is preferred for patients with resectable esophageal cancer.
Methods: Literature was searched in Medline, Embase and the Cochrane library combining relevant 
search terms. Articles that included patients undergoing totally minimally invasive esophagectomy (TMIE) 
or hybrid minimally invasive esophagectomy (HMIE) and compared McKeown with Ivor Lewis procedures 
were included. Studies were excluded if they included >10% of patients undergoing a procedure other 
than MIE McKeown or MIE Ivor Lewis (i.e., transhiatal resections). The primary outcome parameter 
was anastomotic leakage. Secondary outcome parameters were: other complications, reinterventions, 
reoperations, hospital length of stay, ICU length of stay, postoperative mortality, operative time, blood loss, 
R0 resection rate, lymph nodes examined, quality of life and costs. 
Results: Five studies with a total of 1,681 patients undergoing TMIE were included. There were no studies 
comparing HMIE McKeown versus HMIE Ivor Lewis. There were no randomized controlled trials and 
all included studies were cohort studies with a moderate risk of bias. No meta-analysis could be performed 
for R0 resection rate, survival, quality of life and costs because there was insufficient data available for these 
parameters. The incidence of anastomotic leakage did not differ between the groups [relative risk (RR) =1.39, 
95% confidence interval (CI) =0.90–10.38, P=0.14]. TMIE Ivor Lewis was associated with a lower incidence 
of recurrent laryngeal nerve (RLN) trauma (RR =6.70, 95% CI =3.09–14.55, P<0.001), a shorter hospital 
length of stay [standardized mean difference (SMD) =0.17, 95% CI =0.06–0.28, P=0.002] and less blood loss 
(SMD =0.69, 95% CI =0.25–1.12, P=0.002). 
Conclusions: TMIE Ivor Lewis is associated with improved outcome regarding RLN trauma, hospital 
length of stay and blood loss as compared to TMIE-McKeown, but the incidence of anastomotic leakage 
is not different. The evidence is limited, of low quality and at risk for bias. A randomized controlled trial is 
currently being performed in order to demonstrate whether a McKeown or Ivor Lewis procedure should be 
preferred in patients undergoing MIE. 
Keywords: Minimally invasive esophagectomy (MIE); McKeown esophagectomy; Ivor Lewis esophagectomy; 
cervical anastomosis; intrathoracic anastomosis
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Introduction
The annual incidence of esophageal carcinoma is 
increasing (1). Esophagectomy remains the cornerstone 
for curative treatment, most often after neoadjuvant 
therapy (2). Minimally invasive esophagectomy (MIE), 
consisting of hybrid minimally invasive esophagectomy 
(HMIE) or totally minimally invasive esophagectomy 
(TMIE), has been shown to be superior compared to open 
esophagectomy regarding perioperative outcome (3,4) 
without compromising oncologic safety (5,6). This has led 
to a progressive adoption of MIE and currently, 45% of 
all patients worldwide with resectable esophageal cancer 
undergo MIE (7).
Similar to open esophagectomy, MIE can consist of 
transhiatal esophagectomy (8), McKeown esophagectomy (9) 
or Ivor Lewis esophagectomy (10), but Ivor Lewis or 
McKeown procedures are usually performed since they 
allow adequate thoracic lymph node dissection (11,12). 
In patients with esophageal tumors above the level of the 
carina, an Ivor Lewis procedure is unfeasible because it 
might compromise adequate resection margins. For patients 
with lower esophageal or gastroesophageal junction tumors, 
both McKeown and Ivor Lewis procedures are considered 
to be oncologically feasible. Supposed benefits of cervical 
anastomosis are that it is technically less challenging than 
totally minimally invasive intrathoracic anastomosis and 
that if an anastomotic leak occurs, it can be managed more 
easily than intrathoracic leakage. However, intrathoracic 
anastomosis after MIE is believed to be associated with 
a lower incidence of anastomotic leakage and better 
functional results. 
It is currently unknown whether minimally invasive 
McKeown or minimally invasive Ivor Lewis esophagectomy 
should be preferred for these patients and both cervical 
and intrathoracic anastomoses are performed (7). The aim 
of this article is therefore to perform a systematic review 
and meta-analysis of studies comparing minimally invasive 
McKeown esophagectomy with minimally invasive Ivor 
Lewis esophagectomy.
Methods
Literature search
The electronic databases of Medline, Embase and the 
Cochrane Central Register of Controlled Trials databases 
were searched using the following search terms (and 
combinations of these terms): minimal invasive, minimally 
invasive, laparo-thoracoscop*, laparothoracoscop*, 
thoracolaparoscop* OR, thoraco-laparoscop*, laparoscop*, 
hybrid, video assisted thoracic surgery (VATS), video-
assisted, video assisted, thoracoscop* esophagectom*, 
oesophagectom*, resection* oesophagus, oesophageal, 
oesophagal, esophagus, esophageal, esophagal. No language 
restrictions were applied and all results up to December 
2016 were included. Medical ethical approval was not 
sought because no new patient data was obtained for this 
study.
Criteria for selecting studies for this review
Comparative cohort studies or randomized controlled trials 
that included patients undergoing HMIE or TMIE and that 
compared McKeown versus Ivor Lewis procedures were 
included. Exclusion criteria were: less than 10 patients in a 
treatment arm, unclear description of operative technique 
rendering classification into McKeown or Ivor Lewis 
procedures impossible and studies that contained more that 
10% other procedures in one of the arms (i.e., minimally 
invasive transhiatal esophagectomy). VATS procedures and 
hand-assisted laparoscopic surgery (HALS) procedures were 
regarded as minimally invasive and were also included.
All references of studies were screened on title and 
abstract by two authors independently (BK and FvW). All 
studies that were not excluded in the screening stage were 
assessed in full text for eligibility. If discrepancies occurred, 
this was discussed in a meeting and if no consensus could 
be reached, another discussion meeting with a third author 
(CR) was held until consensus was reached. This process 
will be described in a flow chart according to the PRISMA 
statement (13).
Quality assessment
All studies were independently assessed for methodological 
quality by BK and FvW using the Newcastle-Ottawa rating 
scale (14). Discrepancies were resolved in discussion. In case 
of persisting discrepancy, a meeting with a third author (CR) 
was held and discrepancies were discussed until consensus 
was reached. 
Outcome parameters and data extraction
The primary outcome parameter was anastomotic leakage. 
Secondary outcome parameters were: all complications, 
severe complications (CD ≥3), pneumonia, pulmonary 
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Figure 1 Summary of screening and selection process—PRISMA diagram.
Articles identified through database 
searching (n=3,604)
Additional articles identified through 
other sources (n=26)
Articles after duplicates removed 
(n=2,041)
Articles screened 
(n=2,041)
Articles excluded 
(n=2,017)
Full-text articles assessed for 
eligibility (n=24)
Articles included in qualitative 
synthesis (n=5)
Articles included in quantitative 
synthesis (meta-analysis) (n=5)
Full-text articles excluded, with reasons (n=19)
- No comparison of McKeown versus Ivor Lewis (n=11)
- No data per operative approach (n=3)
- <10 patients per treatment group (n=3)
- Unclear whether patients in an outcome group 
underwent McKeown or Ivor Lewis (n=2)
complications, chyle leakage, wound infection, recurrent 
laryngeal nerve (RLN) palsy,  benign anastomotic 
strictures, operating time, blood loss, reoperation rate, 
reintervention rate, hospital length of stay, ICU length of 
stay, postoperative mortality (30-, 90-day and in hospital 
mortality), R0 resection rate, number of lymph nodes 
found, quality of life and costs. Data was extracted and was 
entered into review manager (version 5.3). Continuous 
variables were expressed as median and interquartile ratio or 
range, the mean and SD were estimated from the available 
data by methods described elsewhere (15,16). 
Analysis
Meta-analysis was performed if data on an outcome 
parameter was reported in at least two studies in a way that 
was compatible with meta-analysis. The Mantel-Haenszel 
method for dichotomous data was used, presented as relative 
risks (RR) with 95% confidence intervals (CIs). The inverse 
variance method was used for meta-analysis of continuous 
data; results are presented as standardized mean difference 
(SMD) with 95% CIs. The statistical heterogeneity was 
assessed with I2. In the absence of substantial statistical 
heterogeneity [I2 ≤50% (15)] a fixed-effect model was used. 
In case of substantial heterogeneity (I2 >50%), a random-
effects model was used. Statistical analyses were performed 
with Review Manager (version 5.3). 
Results
Studies
A summary of the screening and selection process according 
to PRISMA (13) is shown in Figure 1. No studies comparing 
McKeown versus Ivor Lewis procedure in patients 
undergoing HMIE were identified. Five studies with 1,681 
patients undergoing TMIE were ultimately included for 
analysis (17-21). The characteristics of the included studies 
are summarized in Table 1. 
Quality assessment
The results of the quality assessment of the included studies 
are shown in Table 2. There were no randomized controlled 
trials. Studies scored 6 or 7 stars out of 9 according to 
the Newcastle-Ottawa rating scale, corresponding to a 
moderate risk of bias. Four studies were retrospective 
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cohort studies and one was a prospective cohort study. One 
study clearly stated that MIE Ivor Lewis procedures were 
predominantly performed in a more recent time period (19). 
This was not described for the other studies.
Heterogeneity
Considerable heterogeneity was found for the outcome 
parameters pulmonary complications (I2 =73%), intensive 
care length of stay (I2 =95%), examined lymph nodes (I2 
=79%), operating time (I2 =99%) and blood loss (I2 =70%). 
For these parameters, a random effects model was used. 
No sensitivity analysis was performed because this was 
considered unfeasible with only 2 or 3 studies available for 
the outcome parameters with high heterogeneity. 
Meta-analysis
The outcome parameters severe complications (CD ≥3), 
pneumonia, wound infection, reintervention, quality of life 
and costs were not reported in any of the included studies. 
The outcome parameters chyle leakage, reoperation, R0 
resection rate were reported, but not enough data was 
available to perform meta-analysis. 
The results of the meta-analysis are shown in Table 3. 
The incidence of anastomotic leakage was 5.2% after 
McKeown esophagectomy and 4.7% after Ivor Lewis 
esophagectomy (RR =1.39, 95% CI =0.90–2.15, P=0.14) 
(Figure 2) .  Totally minimally invasive Ivor Lewis 
esophagectomy was associated with a lower incidence of 
RLN trauma (RR =6.70, 95% CI =3.09–14.55, P<0.001), 
Table 1 Characteristics of included studies
Study Study design N
McKeown 
(N)
Ivor Lewis 
(N)
Type of TMIE Outcome parameters
Hao 2014 Retrospective 
cohort
136 81 55 Thoracolaparoscopic AL, LOS, blood loss, OT, thoracic LN
Luketich 2012 Retrospective 
cohort
1,033 481 530 Thoracolaparoscopic Conversion, AL, gastric tube necrosis, ARDS,  
empyema, MI, heart failure, LOS, ICU LOS, RLN  
trauma, R0, LN, mortality
Nguyen 2008 Prospective 
cohort
104 47 57 Thoracolaparoscopic Blood loss, OT, AL, blood transfusion, major  
complications, mortality, strictures
Rajan 2010 Retrospective 
cohort
336 319 17 Thoracolaparoscopic Blood loss, OT, conversion, AL, LOS, ICU LOS,  
overall complications, pulmonary complications,  
mortality, strictures
Zhai 2015 Retrospective 
cohort
72 40 32 Thoracolaparoscopic Blood loss, OT, AL, blood transfusion, pulmonary  
complications, chylothorax, cardiac arrhythmia,  
delayed gastric emptying, RLN trauma, reoperations, 
LOS, ICU LOS, LN, mortality, strictures
TMIE, totally minimally invasive esophagectomy; AL, anastomotic leakage; RLN, recurrent laryngeal nerve; R0, R0 resection rate; LN, 
lymph nodes examined; ICU, intensive care unit; LOS, length of stay; OT, operating time.
Table 2 Risk of bias assessment
Article Representative Selection
Ascertainment  
of exposure
Demonstration Compatibility Outcome Follow-up
Adequacy 
follow-up
Total 
stars
Hao 2014 1 0 1 1 0 1 1 1 6
Luketich 2012 1 0 1 1 0 1 1 1 6
Nguyen 2008 1 1 1 1 0 1 1 1 7
Rajan 2010 1 0 1 1 0 1 1 1 6
Zhai 2015 1 1 1 1 0 1 1 1 7
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Table 3 Outcomes of meta-analysis*
Parameter No. of studies McKeown (%) Ivor Lewis (%) RR/SMD (95% CI) I2 (%) P value
Anastomotic leakage 5 5.2 4.7 1.39 (0.90–10.38) 40 0.14
Pulmonary complications 2 9.7 16.3 1.16 (0.25–5.26) 73 0.85
Blood transfusion 2 11.5 8.4 1.40 (0.56–3.51) 0 0.48
RLN trauma 2 8.8 1.2 6.70 (3.09–14.55) 0 <0.001
Anastomotic stricture 3 7.4 18 1.30 (0.76–2.22) 49 0.34
Postoperative mortality 5 2.1 1.0 2.18 (0.95–4.98) 0 0.07
Intensive care LOS 2 – – −0.22 (–1.15–0.70) 95 0.63
Hospital LOS 4 – – 0.17 (0.06–0.28) 0 0.002
Examined lymph nodes 2 – – −0.23 (–0.75–0.29) 79 0.39
Operating time 3 – – 2.47 (−0.20–5.14) 99 0.07
Blood loss 3 – – 0.69 (0.25–1.12) 70 0.002
*, If parameters appear in Table 1 as reported outcome parameters but not in this table, the parameter was either reported by only one 
study or the parameters were described in a way that could not be pooled in meta-analysis. RR, relative risk; SMD, standardized mean  
difference; CI, confidence interval; RLN, recurrent laryngeal nerve; ICU, intensive care unit; LOS, length of stay.
Figure 2 Forest plot anastomotic leakage.
a shorter hospital length of stay (SMD =0.17, 95% CI 
=0.06–0.28, P=0.002) and less blood loss (SMD =0.69, 95% 
CI =0.25–1.12, P=0.002) compared to totally minimally 
invasive McKeown esophagectomy (Figures 3-5). There 
were no significant differences between the groups 
regarding the other outcome parameters.
Conclusions
In this meta-analysis, no difference in anastomotic 
leakage was found between McKeown and Ivor Lewis 
esophagectomy in patients undergoing TMIE. The incidence 
of anastomotic leakage was lower than in recent randomized 
controlled trials (2,3) and this might be explained by the 
fact that no standardized definitions of complications were 
used across studies. For example, the largest study that was 
included in this meta-analysis only reported anastomotic 
leakage if a reoperation was required (19). Recently, the 
esophagectomy complications consensus group (ECCG) 
proposed standardized definitions for complications after 
esophagectomy and hopefully this will lead to more uniform 
definitions of complications in future studies (22). 
For open esophagectomy, the anastomotic leakage 
incidence has been shown to be higher after cervical 
anastomosis compared to intrathoracic anastomosis in a 
meta-analysis of randomized controlled trials (23). However, 
the included RCTs were of moderate methodological 
quality and included limited numbers of patients. None 
of the studies included patients undergoing MIE and 
this is important, since especially the minimally invasive 
Study or subgroup
Hao 2014
Luketich 2012
Nguyen 2008
Rajan 2010
Zhai 2015
Total (95% CI)
Total events
Heterogeneity: Chi2 =6.66, df =4 (P=0.16); I2=40%
Test for overall effect: Z =1.48 (P=0.14)
Events
4
26
3
5
12
50
Events
0
23
5
1
3
32
Total
81
481
47
319
40
968
Total
55
530
51
17
32
685
Weight
1.8%
67.3%
14.8%
5.8%
10.3%
100.0%
M-H, fixed, 95% CI
6.15 (0.34, 111.92)
1.25 (0.72, 2.15)
0.65 (0.16, 2.58)
0.27 (0.03, 2.18)
3.20 (0.99, 10.38)
1.39 (0.90, 2.15)
McKeown Ivor Lewis Risk ratio Risk ratio
M-H, fixed, 95% CI
0.01           0.1                 1                 10             100
Favours McKeown  Favours Ivor Lewis
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Figure 3 Forest plot RLN trauma. RLN, recurrent laryngeal nerve.
Figure 4 Forest plot hospital length of stay.
Figure 5 Forest plot blood loss.
creation of an intrathoracic anastomosis is considered to be 
technically challenging and results of open surgery might 
not be applicable to TMIE. HMIE might combine the 
best of both worlds for the Ivor Lewis procedure because 
the technically challenging thoracoscopic creation of 
an intrathoracic anastomosis is avoided by performing a 
thoracotomy and pulmonary complications are reduced by 
performing laparoscopic gastric mobilization (4).
Minimally invasive Ivor Lewis esophagectomy was 
associated with a lower incidence of RLN trauma and less 
blood loss. The difference in the incidence of RLN trauma is 
consistent with the literature regarding open procedures (23) 
and is explained by avoiding a cervical dissection close to 
the RLN. This is important, since it has been shown that 
RLN trauma is associated with increased incidence of 
pulmonary complications, postoperative ventilation time, 
intensive care length of stay and hospital length of stay 
(24-26). The lower blood loss volume that was found 
in patients undergoing minimally invasive Ivor Lewis 
esophagectomy can be explained by omitting a third stage, 
the incision and the associated blood loss.
An interesting finding is that the hospital length of stay was 
shorter after minimally invasive Ivor Lewis esophagectomy 
than after minimally invasive McKeown esophagectomy, 
despite the fact that no differences in postoperative 
complications were observed between the groups. This 
may be explained by the fact that patients with intrathoracic 
anastomosis have a lower incidence of functional morbidity. In 
addition to a lower RLN trauma incidence, fewer swallowing 
problems and a lower incidence of benign anastomotic 
dilatations (27) might contribute to a shorter hospital length 
of stay. Further, prospective research and comparisons of 
other groups are needed in order to assess whether this 
significant difference in functional results after intrathoracic 
anastomosis can be confirmed. Another explanation is that 
the lower length of stay in the Ivor Lewis group might have 
been caused by performance of the minimally invasive Ivor 
Lewis procedure in a more recent era, with increased surgeon 
Study or subgroup
Luketich 2012
Zhai 2015
Total (95% CI)
Total events
Heterogeneity: Chi2 =0.87, df =1 (P=0.35); I2=0%
Test for overall effect: Z =4.81 (P<0.00001)
Events
37
9
46
Events
5
2
7
Total
481
40
521
Total
530
32
562
Weight
68.2%
31.8%
100.0%
M-H, fixed, 95% CI
8.15 [3.23, 20.58]
3.60 [0.84, 15.50]
6.70 [3.09, 14.55]
McKeown Ivor Lewis Risk ratio Risk ratio
M-H, fixed, 95% CI
0.01           0.1                 1                 10             100
Favours McKeown  Favours Ivor Lewis
–1           –0.5           0            0.5             1
Favours Mckeown  Favours Ivor Lewis
Study or subgroup
Hao 2014
Luketich 2012
Nguyen 2008
Zhai 2015
Total (95% CI)
Heterogeneity: Chi2 =0.36, df =3 (P=0.95); I2=0%
Test for overall effect: Z =3.08 (P=0.002)
McKeown
Mean
12.7
8
12.1
23.5
Mean
12.4
7
9.7
20.3
SD
3.93
5.9
12.2
15.1
SD
1.06
5.9
8.1
10.5
Total
81
481
47
40
649
Total
55
530
51
32
668
Weight
10.0%
77.1%
7.5%
5.4%
100.0%
Std. mean difference Std. mean difference
IV, fixed, 95% CIIV, fixed, 95% CI
0.10 [–0.25, 0.44]
0.17 [0.05, 0.29]
0.23 [–0.17, 0.63]
0.24 [–0.23, 0.71]
0.17 [0.06, 0.28]
Ivor Lewis
Study or subgroup
Hao 2014
Nguyen 2008
Zhai 2015
Total (95% CI)
Heterogeneity: Tau2 =0.10; Chi2 =6.60, df =3 (P=0.95); I2=0%
Test for overall effect: Z =3.11 (P=0.002)
McKeown
Mean
110
263
272.9
Mean
86
146
246.3
SD
29.76
179
136.3
SD
10.29
117
82.4
Total
81
47
40
168
Total
55
51
32
138
Ivor Lewis
Weight
35.8%
33.4%
30.8%
100.0%
Std. mean difference
IV, fixed, 95% CI
1.00 (0.64, 1.36)
0.77 (0.36, 1.19)
0.23 (–0.24, 0.69)
0.69 (0.25, 1.12)
Std. mean difference
IV, fixed, 95% CI
Favours McKeown  Favours Ivor Lewis
–2      –1         0        1        2
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experience, increased expertise in postoperative management, 
increased use of enhanced recovery after surgery protocols and 
improved intensive care. However, only one of the included 
studies described this phenomenon (19). Therefore, it remains 
unknown to what extent this selection bias has influenced the 
results of the included studies. 
Taking into account the limitations of the current 
evidence, it remains uncertain whether a McKeown or an 
Ivor Lewis should be preferred for MIE for patients in 
which both procedures are oncologically feasible. To answer 
this question, the ICAN randomized controlled trial is 
currently being conducted in the Netherlands and this trial 
randomizes 200 patients between TMIE McKeown and 
TMIE Ivor Lewis. In addition to postoperative morbidity 
and the severity of complications, this trial is also powered 
for finding differences in quality of life, functional results 
and cost-effectiveness (28).
Strengths of this study are the comprehensive search 
strategy and the fact that this is the first review comparing 
TMIE McKeown versus TMIE Ivor Lewis. Limitations 
are the heterogeneity of the included studies regarding 
definit ions of outcome parameters,  the moderate 
methodological quality and the retrospective character of the 
included studies. In addition, selection bias might have played 
a significant role, but it is unclear to what extent it is present 
in the included studies. More research is needed in order to 
determine whether McKeown or Ivor Lewis MIE should be 
preferred for patients in whom both procedures are feasible. 
Totally minimally invasive Ivor Lewis esophagectomy is 
associated with improved outcome regarding RLN trauma, 
hospital length of stay and blood loss compared to totally 
minimally invasive McKeown esophagectomy. However, the 
evidence is limited, of moderate quality and at risk for bias. 
A randomized controlled trial (Intrathoracic versus Cervical 
ANastomosis after transthoracic esophagectomy: ICAN 
trial) is currently being performed in order to demonstrate 
whether minimally invasive McKeown or minimally invasive 
Ivor Lewis esophagectomy should be preferred for patients 
in which both procedures are oncologically feasible.
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